Claire Forde

13PUBLICATIONS
27CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 19, 2026
A systematic review and meta-analysis of outcomes following active surveillance, surgery and radiotherapy of meningiomas in NF2-related schwannomatosis.

Jack Sheppard, Siddarth Kannan, Jane Halliday

|Feb 04, 2026
Survival Outcomes With or Without Risk-Reducing Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers.

Ashu Gandhi, Sacha J Howell, Elaine F Harkness

|Nov 19, 2025
Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancer.

D Gareth Evans, Robert D Morgan, Claire Forde

|May 11, 2025
UK clinical practice guidelines for the management of patients with constitutional POT1 pathogenic variants.

Olga Tsoulaki, D Gareth Evans, Khushboo Sinha

|Jul 25, 2024
Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years?

D Gareth Evans, Sacha J Howell, George J Burghel

|Jun 26, 2024
NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study.

Claire Forde, Miriam J Smith, George J Burghel

Pageof 3

Frequent Collaborators

9 joint publications

Gareth Evans

7 joint publications

George J Burghel

6 joint publications

Ashu Gandhi

5 joint publications

Miriam Jane Smith